Clinical trial
What is the Diagnostic and Prognostic Accuracy of C-reactive Protein, Serum Procalcitonin and Soluble Urokinase Plasminogen Activator Receptor in the Initial Investigation of Patients With Suspected Community-acquired Pneumonia
NCT04652167 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- What is the Diagnostic and Prognostic Accuracy of C-reactive Protein, Serum Procalcitonin and Soluble Urokinase Plasminogen Activator Receptor in the Initial Investigation of Patients With Suspected Community-acquired Pneumonia
- Lead sponsor
- University of Southern Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 1, 2021
- Completion date
- June 1, 2022
- Enrollment
- 411 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.